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Abstract
 
Listeria monocytogenes
 
 is a facultative intracellular pathogen that induces a cytosolic signaling cas-
cade resulting in expression of interferon (IFN)-
 

 
. Although type I IFNs are critical in viral defense,
their role in immunity to bacterial pathogens is much less clear. In this study, we addressed the
role of type I IFNs by examining the infection of 
 
L. monocytogenes
 
 in BALB/c mice lacking the
type I IFN receptor (IFN-
 

 
/
 

 
R
 

 
/
 

 
). During the first 24 h of infection in vivo, IFN-
 

 
/
 

 
R
 

 
/
 

 
and wild-type mice were similar in terms of 
 
L. monocytogenes
 
 survival. In addition, the intracellular
fate of 
 
L. monocytogenes
 
 in macrophages cultured from IFN-
 

 
/
 

 
R
 

 
/
 
 
 
and wild-type mice was
indistinguishable. However, by 72 h after inoculation in vivo, IFN-
 

 
R
 

 
/
 
 
 
mice were
 

 
1,000-fold more resistant to a high dose 
 
L. monocytogenes
 
 infection. Resistance was correlated
with elevated levels of interleukin 12p70 in the blood and increased numbers of CD11b
 
 
 
mac-
rophages producing tumor necrosis factor 
 
 
 
in the spleen of IFN-
 

 
R
 

 
/
 
 
 
mice. The results of
this study suggest that 
 
L. monocytogenes
 
 might be exploiting an innate antiviral response to promote
its pathogenesis.
Key words: TNF-
 

 
 • CD11b antigen • macrophages • IL-12 • pathogen
 
Introduction
 
Type I IFNs (IFN-
 

 
/
 

 
) are expressed in response to microbial
challenge and act as antiproliferative, immunomodulatory,
and antiviral cytokines (1). The type I IFN family is com-
prised of multiple IFN-
 

 
’s and a single IFN-
 

 
, all using a
common receptor (IFN-
 

 
/
 

 
R) that is expressed on a wide
variety of cell types. In addition to being induced by viruses,
type I IFNs are also produced in response to bacteria and
their products (2, 3). Although IFN-
 

 
/
 

 
R
 

 
/
 
 
 
and IFN-
 

 

 
/
 

 
mice are highly sensitive to a number of viral infections (4,
5), a direct role of type I IFNs in resistance to bacterial
pathogens is not yet appreciated.
Macrophages are mediators of inflammation and critical
effector cells of the innate response. However, they also act
as the primary host cell for many intracellular pathogens,
including 
 
Listeria monocytogenes
 
. 
 
L. monocytogenes
 
 is an intra-
cytosolic human and animal pathogen that is readily phago-
cytosed by macrophages. Once in the host vacuole, 
 
L.
monocytogenes
 
 produces an essential virulence factor encoded
by the 
 
hemolysin
 
 (
 
hly
 
) gene, which enables the bacterium to
permeabilize the vacuolar membrane and enter the cytosol
(6). Entry into this cellular compartment is associated with
induction of a cytosolic signaling cascade characterized by
induction of IFN-
 
 
 
(3). In a recent study, microarray analysis
of macrophage genes induced specifically by virulent 
 
L.
monocytogenes
 
 revealed a response that was dominated by
IFN-inducible genes (7).
In this paper, we addressed the role of type I IFNs in the
immune response to 
 
L. monocytogenes
 
 infection. Surpris-
ingly, mice lacking the IFN-
 

 
/
 

 
R were 400–1,500-fold
more resistant to infection, suggesting that induction of
IFN-
 
 
 
during 
 
L. monocytogenes
 
 intracytosolic growth leads
to enhanced bacterial survival. Resistance to 
 
L. monocytogenes
 
infection in IFN-
 

 
/
 

 
R
 

 
/
 
 
 
mice was associated with an
increase in the number of CD11b
 
 
 
cells producing the
inflammatory cytokine TNF-
 

 
. These data suggest that
intracytosolic 
 
L. monocytogenes
 
 induces IFN-
 
 
 
expression,
thereby suppressing the accumulation of TNF-
 

 
–producing
phagocytic cells at sites of bacterial growth and promoting
infection.
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Mary O’Riordan’s present address is Dept. of Microbiology and Im-
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Materials and Methods
 
Animals.
 
IFN-
 

 
/
 

 
R
 

 
/
 
 
 
mice in the 129Sv background were
originally generated by Müller et al. (8). The 129Sv animals were
backcrossed to the BALB/c background for seven generations.
Heterozygotes were bred to obtain homozygote knockouts,
which were intercrossed for one or two generations. Because
IFN-
 

 
/
 

 
R
 

 
/
 
 
 
mice are susceptible to viral infections, serum
from resting animals was tested and found to be negative for anti-
bodies to a panel of murine viruses. In addition, no inflammatory
cytokines were detected in the blood of IFN-
 

 
/
 

 
R
 

 
/
 
 
 
mice and
the hematocrit differential showed no increased levels of circulat-
ing neutrophils, monocytes, or lymphocytes. Age- and sex-
matched BALB/c control mice were obtained from The Jackson
Laboratory and Charles River Laboratories.
 
Cell Culture and Bacteria.
 
Bone marrow–derived macro-
phages (BMDMs) were isolated using media containing 30% L
cell–conditioned media as a source of CSF-1 and resident perito-
neal macrophages were isolated as described previously (9, 10). 
 
L.
monocytogenes
 
 10403S and 
 

 
hly L. monocytogenes
 
 DP-L2161 were
used in this work. Bacteria for in vitro (3) and in vivo infections
(11) were prepared as described previously.
 
In Vivo L. monocytogenes Infections.
 
6–8-wk-old mice were in-
jected intravenously with 
 
L. monocytogenes
 
 in 200 
 

 
l PBS. Mice
were killed 1–7 d after inoculation or were rechallenged 3–4 wk
after primary inoculation. CFUs in the spleen and liver were deter-
mined as described previously (11). Nonterminal ocular and termi-
nal heart puncture bleeds were performed under isofluorane anes-
thesia. Serum was obtained using serum separator tubes (Capiject;
Terumo) or by removing blood clots after overnight incubation at
4
 

 
C, followed by centrifugation to remove excess RBCs.
 
Ex Vivo Stimulation of Splenocytes.
 
Heat-killed 
 
L. monocytoge-
nes
 
 (HKLM) were prepared as described previously (12). Single
cell suspensions were prepared from collagenase D (Roche)–
treated spleens. RBCs were lysed using NH
 
4
 
Cl
 
2
 
. For detection
of secreted TNF-
 

 
, 5 
 
	 
 
10
 
5 
 
splenocytes/ml of RPMI supple-
mented with 10% fetal bovine serum and penicillin/streptomycin
(RPMI
 

 
) were plated in tissue culture (TC)-treated plates and ei-
ther left untreated or stimulated with 4 
 
	 
 
10
 
6 
 
HKLM/ml for 18 h.
TNF-
 

 
–expressing cells in the spleen were determined by intra-
cellular cytokine staining as described previously (13). In brief,
5 
 
	 
 
10
 
5 
 
splenocytes/ml of RPMI
 
 
 
were cultured in TC-treated
plates 
 

 
 
4 
 
	 
 
10
 
6 
 
HKLM/ml for 4 h in the presence of 1 
 

 
g/ml
brefeldin A (GolgiPlug; BD Biosciences). Cells were resuspended
with gentle pipetting and the remaining adherent cells were
treated with Cell Stripper (CellGro) and harvested. Cells were
stained for cell surface markers using anti–CD11b-FITC (M1/70),
anti–CD11c-PE, anti–GR-1–FITC (RB6-8C5), anti–CD4-FITC
(GK1.5; all from eBioscience), and anti–CD8-PerCP (53-6.7) and
anti–CD3e-APC (145-2C11BD; both from BD Biosciences).
Cells were fixed in Cytofix/Cytoperm, permeabilized with Perm/
Wash buffer (BD Biosciences), and incubated with anti–TNF-
 

 
–
PE (MP6-XT22) and Mac-3–FITC (M3/84; both from eBio-
science). Samples were acquired on a FACSCalibur™ flow cy-
tometer and data were analyzed using CELLQuest™ software
(BD Immunocytometry System) and FlowJo (Tree Star, Inc.).
 
In Vitro L. Monocytogenes Infection.
 
Growth curves in BMDMs
and peritoneal macrophages were performed as described previ-
ously (10), except the BMDM experiments were performed
in the presence of CSF-1. For mRNA analysis, BMDMs were
seeded onto TC-treated dishes, incubated overnight, and infected
with 
 
L. monocytogenes
 
 at a multiplicity of infection (MOI) of 10:1
for wild-type 
 
L. monocytogenes
 
 and 100:1 for the 
 

 
hly
 
 strain for 30
min. These inoculation doses were used to achieve a similar
number of wild-type and 
 

 
hly
 
 bacteria per cell at the end of the
experiment. The infected cells were washed, gentamicin was
added 30 min later, and RNA was isolated 6 h after inoculation
using the RNeasy Mini kit (QIAGEN) according to the manu-
facturer’s instructions. For detection of DNA fragmentation,
BMDMs were seeded onto glass coverslips, incubated overnight,
and infected with 
 
L. monocytogenes at an MOI of 16:1 for 30 min.
The infected cells were treated as for the RNA isolation de-
scribed above, except at 8 h after inoculation monolayers were
fixed with 3.2% paraformaldehyde. The in situ cell death detec-
tion kit (Roche) was used according to the manufacturer’s in-
structions. Stained coverslips were mounted using Vectashield
with DAPI (Vector Laboratories). 10 frames per condition were
captured using a 60	 objective and the number of TdT-medi-
ated dUTP nick-end labeling nuclei out of the total number of
nuclei was quantified. The experiment was performed twice.
ELISA. Serum and supernatant samples were assayed simulta-
neously for levels of IFN-, IL-12p70, TNF-, MCP-1, IL-6,
and IL-10 using the mouse inflammation cytometric bead array kit
(BD Biosciences) according to the manufacturer’s instructions, ex-
cept 20 l of sample, 4 l of each antibody-conjugated bead, and
20 l of PE-conjugated detection reagent were used per reaction.
Data was acquired on a Beckman Coulter XL flow cytometer and
analyzed using BD Biosciences analysis software. For detection of
serum TNF-, a TNF- ELISA kit (eBioscience) was used ac-
cording to the manufacturer’s instructions. Results were obtained
using a plate reader (SpectraMax 340; Molecular Devices).
Quantitative PCR. To synthesize cDNA, 1.5 g of total
RNA, M-MLV reverse transcriptase, Random Primers, and
RNaseOUT ribonuclease inhibitor (Invitrogen) were used. SYBR®
Green-based quantitative PCR amplification was performed in
96-well plates using SYBR® Green PCR core reagents (Applied
Biosystems), the Stratagene Mx3000P Real-Time PCR System,
and a 60C annealing temperature. Results were analyzed with
Stratagene Mx3000P software. The following mouse primer se-
quences were designed using Applied Biosystems Primer Express
software: ifnb-F: 5-ctggagcagctgaatggaaag; ifnb-R: 5-cttgaagtcc-
gccctgtaggt;  actin-F: 5-aggtgtgatggtgggaatgg;  actin-R: 5-
gcctcgtcacccacatagga; tnfa-F: 5-gcaccaccatcaaggactcaa; and tnfa-R:
5-tcgaggctccagtgaattcg.
Results and Discussion
IFN-/R Mice Are 400–1,500-fold More Resistant to
L. monocytogenes Infection. To evaluate the role of type I
IFNs during infection with L. monocytogenes, we infected
BALB/c and IFN-/R/ mice with 2 	 104 L. monocyto-
genes (equivalent to 1 LD50 in BALB/c mice; reference 10),
and CFUs in the spleen and liver were monitored (Fig. 1, A
and B). After 1 d of infection, bacterial numbers were indis-
tinguishable between the wild-type and IFN-/R/
mice in the liver and similar in the spleen. As expected, the
bacterial load in both organs continued increasing logarith-
mically in BALB/c mice. However, the number of CFUs
only decreased over the time course in IFN-/R/ mice.
At 3 d after inoculation, there were three logs more bacteria
in the spleens of the wild-type mice compared with the
IFN-/R/ mice. During low dose L. monocytogenes in-
fection (equivalent to 0.1 LD50 in BALB/c mice), the results
were not as dramatic, yet differences in bacterial numbers at
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3 d after inoculation were still 40-fold in the spleen and
20-fold in the liver (Table I). These data suggest that type I
IFNs favor the growth of L. monocytogenes in vivo.
Adaptive Immunity to L. monocytogenes Is Unchanged in the
Absence of Type I IFN Signaling. Recently, there has been
a heightened interest in the function that type I IFNs might
play in bridging innate and adaptive immunity. Type I IFNs
are known to induce the proliferation of memory CD8 T
cells through the induction of IL-15 and have been impli-
cated in the persistence of both CD4 and CD8 memory
T cells by preventing apoptosis (14, 15). However, at least
during some viral infections, IFN-/R/ mice are able
to mount normal T cell responses (8, 16). To determine
whether IFN-/R/ mice are able to mount an adaptive
immune response to L. monocytogenes, we immunized IFN-
/R/ and BALB/c mice with L. monocytogenes and chal-
lenged them 3–4 wk later (Fig. 1 C). In contrast to the re-
sults seen in naive animals, both wild-type and IFN-/
R/ mice displayed equivalent numbers of bacteria in the
spleen 48 h after challenge inoculation. Although the adap-
tive immune response against L. monocytogenes is known to
be dependent on CD8 T cells (17), our data suggest that
IFN-R/ mice mount a fully productive adaptive im-
mune response to L. monocytogenes.
Interaction of L. monocytogenes with Macrophages In Vitro.
Macrophages are the primary host cell for L. monocytogenes
in vivo. To identify any potential differences in the interac-
tion between L. monocytogenes and macrophages in the
absence of type I IFN signaling, we characterized L. mono-
cytogenes infection of primary cultured macrophages. In-
tracellular bacterial growth/survival was indistinguishable
in both wild-type and IFN-/R/ BMDMs (Fig. 2 A),
and in resident peritoneal macrophages (not depicted). Be-
cause type I IFNs promote apoptosis under some condi-
tions (1, 18), we analyzed apoptosis of BALB/c and IFN-
/R/ BMDMs infected with L. monocytogenes for 8 h
by the TdT-mediated dUTP nick-end labeling assay. At
this time point, infected cells contained 20–100 bacteria
Figure 1. L. monocytogenes infection of BALB/c
and IFN-/R mice. Naive BALB/c and
IFN-/R/ mice (three per group) were in-
fected with 2 	 104 wild-type L. monocytogenes
and bacterial growth in the spleen (A) and liver
(B) was followed over 3 d. (C) BALB/c and
IFN-R/ mice were immunized with 2 	
103 L. monocytogenes 3–4 wk before challenge
with 4 	 104 bacteria. Naive animals were in-
fected with 4 	 104 bacteria. Dashed line denotes
limit of detection. CFUs from the spleen 48 h
after inoculation are shown. Data represents two
separate experiments.
Table I. Serum Cytokine Levels During L. monocytogenes Infection of BALB/c and IFN-/R Mice
Days after inoculation
1 2 3 4
Spleen CFUa 1.2 	 105 
 2.3 	 104 1.2 	 105 
 1.4 	 104 4.9 	 105 
 2.4 	 105 2.5 	 104 
 6.2 	 103 BALB/c
6.5 	 104 
 1.7 	 104 3.3 	 104 
 5.9 	 103 1.1 	 104 
 4.6 	 103 1.3 	 103 
 7.9 	 101 IFN-/R
Liver CFU 7.8 	 104 
 1.7 	 104 3.0 	 104 
 1.3 	 104 7.4 	 104 
 3.2 	 104 3.4 	 104 
 9.6 	 103 BALB/c
4.2 	 104 
 1.7 	 104 2.2 	 104 
 7.2 	 103 3.3 	 103 
 1.6 	 103 8.8 	 103 
 5.0 	 103 IFN-/R
IL-12p70b 24 
 9 10 
 4 25 
 6 9 
 5 BALB/c
89 
 26 103 
 20 35 
 13 0 IFN-/R
IFN- 351 
 61 735 
 111 372 
 125 48 
 23 BALB/c
299 
 57 237 
 28 26 
 5 7 
 2 IFN-/R
MCP-1 522 
 71 395 
 54 182 
 8 38 
 16 BALB/c
515 
 63 180 
 27 84 
 10 58 
 16 IFN-/R
IL-6 126 
 31 101 
 15 80 
 26 18 
 6 BALB/c
166 
 49 81 
 14 23 
 4 12 
 3 IFN-/R
aMice were infected with 1.2 	 103 L. monocytogenes. Average CFU per organ from four mice per group 
 SEM is shown. Values in bold are signif-
icantly different between BALB/C and IFN-/R mice (P  0.03) according to the Mann-Whitney nonparametric test.
bMice were bled immediately before death. Average cytokine pg/ml serum 
 SEM is shown. Values in bold are significantly different between
BALB/C and IFN-/R mice (P  0.05).
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each. The percentage of apoptotic cells was similar be-
tween wild-type and IFN-/R/ BMDMs (9 and 7%,
respectively). We concluded that type I IFN signaling un-
der the in vitro conditions described here did not sensitize
macrophages to L. monocytogenes–induced apoptosis.
Macrophages are an important source of cytokines during
listeriosis (19). To ensure that signaling originating from pri-
mary infected cells is intact in the absence of the IFN-/
R, we characterized the expression of cytokines down-
stream of two distinct pathways of microbial detection. Cy-
tosolic but not vacuolar L. monocytogenes induces IFN-
expression (3), which is MyD88 and TRIF independent
(unpublished data and reference 7), but IRF-3 dependent
(20). In contrast, surface or vacuolar detection of bacterial
products leads to induction of TNF- via the Toll-like re-
ceptor pathway (17). Expression of both IFN- and TNF-
was similar in L. monocytogenes–infected BALB/c and IFN-
/R/ BMDMs (Fig. 2, B–D). We conclude that L.
monocytogenes interaction with its primary host cell proceeds
normally in the absence of type I IFN signaling.
Increased IL-12p70 and TNF-, But Not IFN-, in IFN-
/R Mice. To gain insight into the resistance of IFN-
/R/ mice to L. monocytogenes, we quantified the levels
of several inflammatory cytokines in the serum of BALB/c
and IFN-/R/ mice infected with a low dose of L.
monocytogenes (Table I). Consistent with the greater number
of CFUs per organ, levels of IFN-, IL-6, and MCP-1
were higher in wild-type mice than in IFN-/R/
mice. In contrast, there was a 10-fold increase in IL-12p70
serum levels in the IFN-R/ mice 48 h after inocula-
tion, even though at this time point IFN-/R/ spleens
harbored fourfold fewer CFUs than wild-type. These data
were confirmed by analyzing IL-12p70 and IFN- serum
levels in BALB/c and IFN-/R/ mice infected with a
higher dose of L. monocytogenes (Fig. 3 A).
A complex link between type I IFNs, IL-12, and IFN-
induction has been established (21). Type I IFNs can in-
hibit production of IL-12 (22) and our results concur with
this finding. In addition, type I IFNs have been shown to
inhibit IL-12–induced IFN- production (21). However,
the increased IL-12 levels in the absence of type I IFNs we
report here did not lead to increased IFN- expression.
However, another cytokine, IL-18, has been shown to
synergize with type I IFNs to induce NK and T cell IFN-
expression (23). Because IFN- is known to contribute to
protection against L. monocytogenes (19), the findings of ele-
vated IL-12 yet decreased IFN- in the IFN-/R/
mice do not explain their resistance to this pathogen.
TNF- is essential for controlling L. monocytogenes infec-
tions and acts synergistically with IFN- to enhance mac-
rophage killing of L. monocytogenes (9, 19). However,
TNF- is rapidly cleared from the serum (24). Consistent
with this, we detected low levels of TNF- in the serum
from both BALB/c and IFN-/R/ mice during high
dose L. monocytogenes infection (2 	 104; not depicted).
Therefore, we isolated splenocytes from BALB/c and IFN-
/R/ mice infected 48 h previously with L. monocytoge-
nes and directly measured TNF- secretion in the presence
Figure 2. IFN-/R BMDMs support normal L. monocytogenes
growth. BALB/c and IFN-R/ BMDMs were (A) infected with
wild-type L. monocytogenes and bacterial growth was monitored in the
presence of 50 g/ml gentamicin. Black diamonds, BALB/c; gray dia-
monds, IFN-R/. BMDMs were infected with an MOI of 10:1
wild-type or 100:1 hly L. monocytogenes, which does not enter the host
cytosol and does not grow intracellularly, and ifnb (B) or tnfa (C) mRNA
levels (normalized to  actin) and TNF- supernatant protein levels (D)
were quantified 6 h after inoculation. All experiments were performed at
least twice.
Figure 3. Elevated IL-12p70 and TNF-, but
not IFN-, in the absence of type I IFN signaling.
(A) BALB/c and IFN-R/ mice were infected
with 2.5 	 104 wild-type L. monocytogenes, bled 24 h
after inoculation, and serum was assayed for cyto-
kine levels. Data represents the average from seven
mice per group over two separate experiments 

SEM. Splenocytes from uninfected BALB/c and
IFN-/R/ mice (B) or from mice infected 48 h
previously with 2 	 104 L. monocytogenes (C) were
cultured 
 4 	 106 HKLM/ml for 18 h. Culture
supernatants were assayed for TNF-. Data represent
the average from six mice per group over two sepa-
rate experiments 
 SEM.
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or absence of HKLM stimulation ex vivo (Fig. 3 C). IFN-
/R/ splenocytes produced fivefold greater TNF-
than BALB/c splenocytes. In contrast, BALB/c and IFN-
/R/ splenocytes from uninfected animals produced
equivalent low levels of TNF- upon HKLM stimulation
(Fig. 3 B).
IFN-/R Mice Contain More TNF-–producing
CD11b Cells in the Spleen During L. monocytogenes Infec-
tion. To identify the cell type(s) responsible for producing
the increased amount of TNF- in the IFN-/R/
mice, we performed intracellular cytokine staining of sple-
nocytes from BALB/c and IFN-/R/ mice infected
for 2 d with L. monocytogenes. Very few CD4 or CD8 T
cells produced TNF- in either BALB/c or IFN-/R/
mice (not depicted). However, fourfold more TNF-–
producing CD11b cells were detected in the infected
IFN-/R/ spleens as compared with wild-type (Fig. 4,
A and C). Accounting for this increase, both the total num-
ber of CD11b cells (Fig. 4 B) and the percentage produc-
ing TNF- (35% of IFN-/R/ CD11b cells, 22% of
BALB/c upon HKLM stimulation; P  0.045, Mann-
Whitney nonparametric test) were greater in the absence of
type I IFN signaling.
Recently, a population of CD11bint/Mac-3high/CD11cint
cells capable of producing TNF- (TipDCs) was shown to
be associated with enhanced L. monocytogenes clearance
(25). To determine whether TipDCs were responsible for
the enhanced TNF- production in IFN-/R/ mice,
we performed further flow cytometric analysis. Interest-
ingly, the total numbers of both TipDCs (R1, CD11bint/
Mac-3high/CD11c) and a distinct CD11b cell population
(R2, CD11bhigh/Mac-3int/high/CD11c) were approxi-
mately twofold greater in the infected IFN-/R/ mice
compared with wild-type (Fig. 4 D and not depicted).
However, the total number of TipDCs producing TNF-
was similar in both BALB/c and IFN-/R/ mice (Fig.
4 E). In contrast, there were fourfold more CD11bhigh/
Mac-3int/high/CD11c cells producing TNF- in the IFN-
/R/ mice compared with wild-type. These data sug-
gest that a CD11b cell population distinct from TipDCs is
responsible for the majority of the additional TNF- pro-
duced by IFN-/R/ splenocytes.
Figure 4. Increased number of CD11b TNF-–
producing cells in IFN-R mice. Splenocytes
from uninfected (uninf) or L. monocytogenes–infected
(inf) BALB/c and IFN-R/ mice were cultured

 4 	 106 HKLM/ml for 4 h. The absolute number
of splenocytes was similar between BALB/c and
IFN-R/ mice. Cells were stained for cell sur-
face markers and intracellular TNF- and Mac-3.
(A–C) Cells were stained for CD11b, CD3e, and
TNF-, gated on CD3e events, and expression of
CD11b and TNF- was analyzed. Data represents
results from six mice per group over two separate
experiments. (A) Representative dot plots from in-
fected mouse splenocytes. Average percentage of
total splenocytes 
 SEM that are TNF-–producing
CD11b (top left) and CD11b (top right) cells are
shown. (B) Average percentage of total splenocytes
that are CD11b/CD3e. (C) Average percentage
of total splenocytes stimulated with 4 	 106
HKLM/ml that are CD11b/TNF- or CD11b/
TNF-. (D and E) Cells stimulated with 4 	 106
HKLM/ml were stained for CD11b, Mac-3, and
TNF-. (D) Representative dot plots from one of
three mice per group. Values shown are average
percentage of total splenocytes 
 SEM residing
within the R1 and R2 populations. (E) Cells within
the R1 and R2 gates were analyzed for intracellular
TNF- staining. Average percentage of total spleno-
cytes 
 SEM that are CD11bint/Mac-3high/TNF-
(R1) or CD11bhigh/Mac-3int/high/TNF- (R2).
Statistical significance was determined by using the
Mann-Whitney nonparametric test. *, P  0.081;
**, P  0.005.
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The increased number of CD11b cells during L. monocy-
togenes infection in the absence of type I IFN signaling sug-
gests that either (a) these cells are normally eliminated during
listeriosis, (b) IFN-/ normally prevent their expansion or
differentiation from a precursor cell, or (c) an increased
number traffic to sites of L. monocytogenes infection in the ab-
sence of type I IFN signaling. Type I IFNs have a role in de-
termining cell fate by a number of mechanisms: induction of
apoptosis, proliferation, activation, or maturation, depending
on the environmental context (1, 18). Although we cannot
at this time eliminate the latter possibilities, we favor the hy-
pothesis that the proapoptotic properties of IFN-/ sup-
press an innate immune response mediated by CD11b cells.
Apoptosis of splenocytes has been observed during L. mono-
cytogenes infection (26). Recently, a link between type I
IFNs and apoptosis of naive T cells during infection with L.
monocytogenes has been suggested (27). This apoptosis may
result from induction of T cell CD69, an early activation
marker, in the absence of other activation signals (27, 28).
Similarly, we observed fewer CD69 splenocytes from IFN-
/R/ mice (not depicted). Indeed, O’Connell et al. (29)
find extensive apoptosis in the spleens of L. monocytogenes–
infected C57BL/6 mice only in the presence of type I IFN
signaling. Extensive analysis will be required to determine
the identity of the apoptotic cells seen in wild-type but not
IFN-/R/ mouse spleens during L. monocytogenes infec-
tion. Because we observed a larger population of CD11b
cells in the infected IFN-/R/ mice, we suggest that
these cells are normally eliminated in the wild-type animal
via induction of apoptosis.
Macrophages act as both primary host cells and effector
cells during listeriosis. The results of this paper show that
type I IFNs do not affect the interaction of L. monocytogenes
with its primary host cell in terms of intracellular growth,
induction of apoptosis, and expression of at least two dif-
ferent cytokines representing distinct signaling pathways.
However, we show that a population of CD11b cells dis-
tinct from TipDCs are enhanced in both numbers and ef-
fector function (TNF- expression) during L. monocytogenes
infection of mice in the absence of type I IFN signaling.
Additional studies will reveal whether other effector func-
tions besides TNF- contribute to CD11b cell–mediated
resistance to L. monocytogenes.
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